Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - September 2009

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for September 2009 (PDF).

This issue contains Hot Topics on the possible association between insulin glargine and an increased risk of cancer, an update on the efficacy of measures implemented to reduce risk of illicit use of ephedrine and pseudoephedrine and information about the new warnings and tighter controls for codeine and dihydrocodeine containing analgesics.

Additionally, there is a Stop Press regarding the interaction between proton pump inhibitors and clopidogrel that clarifies alternative gastrointestinal therapies should not include cimetidine.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - September 2009' on Email Share 'Drug Safety Update - September 2009' on Delicious Share 'Drug Safety Update - September 2009' on Digg Share 'Drug Safety Update - September 2009' on Facebook Share 'Drug Safety Update - September 2009' on Google+ Share 'Drug Safety Update - September 2009' on reddit Share 'Drug Safety Update - September 2009' on StumbleUpon Share 'Drug Safety Update - September 2009' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - September 2009”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,431 spam comments.

atomic-wealth
fond-illness
summer